Accepted Manuscript High Fat Diet Aggravates Cardiomyopathy In Murine Chronic Chagas Disease Kezia Lizardo, Janeesh Plakkal Ayyappan, Min-Hui Cui, Rashmi Balasubramanya, Linda A. Jelicks, Jyothi Nagajyothi PII:
S1286-4579(18)30146-1
DOI:
10.1016/j.micinf.2018.07.001
Reference:
MICINF 4598
To appear in:
Microbes and Infection
Received Date: 13 April 2018 Revised Date:
29 May 2018
Accepted Date: 7 July 2018
Please cite this article as: K. Lizardo, J.P. Ayyappan, M.-H. Cui, R. Balasubramanya, L.A. Jelicks, J. Nagajyothi, High Fat Diet Aggravates Cardiomyopathy In Murine Chronic Chagas Disease, Microbes and Infection (2018), doi: 10.1016/j.micinf.2018.07.001. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
1 2
HIGH FAT DIET AGGRAVATES CARDIOMYOPATHY IN MURINE CHRONIC CHAGAS DISEASE
3 Kezia Lizardoa*, Janeesh Plakkal Ayyappana, Min-Hui Cuib,c, Rashmi Balasubramanyad, Linda A.
5
Jelicksc, Jyothi Nagajyothia*#
RI PT
4
6
7
a
8
New Jersey Medical School, Newark ,USA
9
b
M AN U
Department of Radiology2, Medicinec, Albert Einstein College of Medicine, 1300 Morris Park Avenue,
10
Bronx, New York, USA
11
d
Department of Radiology, Mercy Medical Center, Springfield, Massachusetts, USA
TE D
12
13
* Authors contributed equally to this article
EP
14
SC
Department of Microbiology, Biochemistry and Molecular Genetics, Public Health Research Institute,
15
16
#
17
Jyothi F Nagajyothi
18
225, Warren Street,
19
Newark, NJ- 07103
20
Fax: 973-854-3101
21
Telephone: 973-854-3450
22
Email:
[email protected]
AC C
Corresponding Authors:
1
ACCEPTED MANUSCRIPT
ABSTRACT
24
Infection with Trypanosoma cruzi, the etiologic agent in Chagas disease, may result in heart disease. Over
25
the last decades, Chagas disease endemic areas in Latin America have seen a dietary transition from the
26
traditional regional diet to a western style, fat rich diet. Previously, we demonstrated that during acute
27
infection high fat diet (HFD) protects mice from the consequences of infection-induced myocardial
28
damage through effects on adipogenesis in adipose tissue and reduced cardiac lipidopathy. However, the
29
effect of HFD on the subsequent stages of infection – the indeterminate and chronic stages – has not been
30
investigated. To address this gap in knowledge, we studied the effect HFD during indeterminate and
31
chronic stages of Chagas disease in the mouse model. We report, for the first time, the effect of HFD on
32
myocardial inflammation, vasculopathy, and other types of dysfunction observed during chronic T. cruzi
33
infection. Our results show that HFD perturbs lipid metabolism and induces oxidative stress to exacerbate
34
late chronic Chagas disease cardiac pathology.
35
KEY WORDS
36
Chagas disease, chagasic cardiomyopathy, High fat diet, lipid metabolism, mitochondrial dysfunction,
37
RAGE, inflammation
EP
38
TE D
M AN U
SC
RI PT
23
1. INTRODUCTION
40
Chagas disease, caused by the parasite Trypanosoma cruzi, is a potentially deadly disease endemic in
41
Latin America [1, 2]. Approximately 30% of the infected patients develop cardiac problems, including
42
Chronic Chagasic Cardiomyopathy (CCM), which is associated with high mortality [3,4]. The
43
pathogenesis of CCM is not completely understood. Many factors, including parasite-induced myocardial
44
damage, immune-mediated myocardial injury, mitochondrial dysfunction and microvascular and
AC C
39
2
ACCEPTED MANUSCRIPT
neurogenic disturbances, have been suggested as causes for the development of CCM [5-9]. Furthermore,
46
no effective drugs or vaccines are available to counteract or prevent CCM [3].
47
Chagas disease in human patients characteristically presents as two phases, acute and chronic, each with
48
distinct clinical features [10, 17]. The chronic phase can take one of two forms: (i) the indeterminate
49
form, which represents about 60–70% of the cases and does not present any clinical symptoms, and (ii)
50
the determinate form, which is characterized by cardiac and digestive pathologies [10]. Chronic chagasic
51
cardiomyopathy (CCM) is the most clinically important chronic form of Chagas' disease due to its high
52
rate of morbidity and mortality in the endemic regions of Chagas disease, with a significant medical and
53
social impact [11].
54
In the endemic regions of Chagas disease, as elsewhere, traditional food patterns rich in complex
55
carbohydrates, micronutrients, fiber, and phytochemicals are being replaced with diets high in refined
56
sugars, animal products, and highly processed foods [18, 19]. However, how such a diet transition may
57
influence the outcome of chronic Chagas disease has not been studied. Various murine experimental
58
Chagas models have been used to understand the molecular mechanism(s) involved in the pathogenesis of
59
acute and chronic Chagas disease [12-16]. T. cruzi infected CD1 mice usually present with three distinct
60
phases of the disease (acute, indeterminate and cardiac chronic) based on the serum parasitemia and
61
inflammatory signaling, and are therefore a suitable model to investigate the factors responsible for the
62
pathogenesis of the disease and the transition from the indeterminate stage to determinate cardiac stage
63
(CCM) [12-15]. It has been demonstrated that acute infection in a murine model of Chagas disease is
64
associated with alterations in cardiac lipid metabolism and lipiodopathy, which in turn causes myocardial
65
injury, cardiac oxidative stress and inflammation [13-16]. We also demonstrated that during acute T. cruzi
66
infection, a high fat diet (HFD, 60% fat calories) significantly protected the infected mice from mortality
67
by regulating cardiac immuno-metabolic signaling via increased adiposity in the adipose tissue [15,16].
AC C
EP
TE D
M AN U
SC
RI PT
45
68 3
ACCEPTED MANUSCRIPT
In this study we investigated the effect of HFD on regulating cardiac pathology during the indeterminate
70
and chronic cardiac stages in the murine model of Chagas disease. In particular, we examined the effect
71
of HFD on cardiac lipid metabolism, oxidative stress, and inflammatory signaling to analyze their roles in
72
causing myocardial inflammation, vasculopathy, and other dysfunctions observed during chronic T. cruzi
73
infection using an established murine Chagas disease model. The results shed light on how metabolic
74
regulation influences the development of cardiomyopathy and heart failure during chronic Chagas
75
disease.
SC
RI PT
69
76 2. MATERIALS AND METHODS:
M AN U
77 78
2.1 Ethical approval: All animal experimental protocols were approved by the Institutional Animal Care
80
and Use Committee (IACUC) of the Albert Einstein College of Medicine (No. 20130202) and the
81
Rutgers Biomedical and Health Sciences (No. 15107), adhere to the National Research Council
82
guidelines (Guide for the Care and Use of Laboratory Animals: Eighth Edition, Washington, DC: The
83
National Academies Press, 2011).
84
TE D
79
2.2 Experimental animal model: The Brazil strain of T. cruzi was maintained by passage in C3H/Hej
86
mice (Jackson Laboratories, Bar Harbor, ME). Male CD-1 mice (Jackson Laboratories) were infected
87
intraperitoneally (i.p.) at 6–8 weeks of age with 103 trypomastigotes of the Brazil strain [20]. Mice were
88
maintained on a 12-hour light/dark cycle. Acute infection results in increased parasitemia and serum
89
inflammatory cytokines [14]. The parasitemia and the levels of pro-inflammatory signaling significantly
90
reduces after 30dpi in T. cruzi infected CD1 mice [14, 17]. In this Experiment (replicated), starting at the
91
day of 35 post infection (after acute infection), mice were randomly divided into two groups (n = 20 per
92
group) and fed on either high fat diet (HFD; 60% fat D12492 Research Diets, Inc., New Brunswick, NJ)
93
or regular diet (RD, 10% fat D12450 Research Diets, Inc., New Brunswick, NJ) [14]. Uninfected mice 4
AC C
EP
85
ACCEPTED MANUSCRIPT
94
were fed on either HFD (n=20) or RD (n=20) and used as respective controls in all the experiments
95
(Experimental design Supplemental Fig.1A). Mice were euthanized and hearts were harvested for histological and molecular analysis at early
97
chronic stage (d120pi) and late chronic stage (d160pi) [14, 20]. Plasma samples were obtained from 75
98
µl of blood collected from the orbital venous sinus (using isoflurane anesthesia) 160 days post infection
99
(dpi).
RI PT
96
SC
100
2.3 Magnetic resonance imaging (MRI) analysis: Cardiac gated MRI was performed on uninfected and
102
infected mice at early and late chronic stages of infection (100 and 150 dpi, before sacrificing the mice at
103
d120pi and 160pi respectively) were imaged using a 9.4 T Varian Direct Drive animal magnetic
104
resonance imaging and spectroscopic system (Agilent Technologies, Inc. Santa Clara, CA) as previously
105
published [14]. Briefly, anesthesia was induced with 2% isoflurane in air, mice were positioned supine
106
inside an MR compatible holder and positioned within a 35-mm ID quadrature 1H volume coil
107
(Molecules2Man Imaging Co., Cleveland, OH). Body temperature was maintained at 34 ~35 °C using
108
warm air with feedback from a body surface thermocouple. A respiratory sensor balloon was taped onto
109
the abdomen. Cardiac (ECG electrodes inserted subcutaneously in front left paw and rear right paw) and
110
respiratory signal (from sensor balloon taped to the abdomen) were continuously monitored and used for
111
MR gating/triggering by an SA Monitoring and Gating System (Small Animal Instruments, Inc., Stony
112
Brook, NY). Ten to fourteen 1-mm-thick slices without gap was acquired in short-axis orientation
113
covering the entire heart using an ECG-triggered and respiratory gated multi-frame tagged cine sequence.
114
The imaging parameters used were field of view (FOV) of 40 x 40 mm2, matrix size of 256 x 256, TE of
115
2.6 ms, TR of 5.5 ms, flip angle of 25°, number of averages of 2. The number of frames was twelve to
116
eighteen. Data were transferred to a PC and analyzed using MATLAB-based software. Left ventricle
117
(LV) and right ventricle (RV) dimensions in millimeters were determined from the images representing
AC C
EP
TE D
M AN U
101
5
ACCEPTED MANUSCRIPT
118
end-diastole. The left ventricular wall is the average of the anterior, posterior, lateral, and septal walls.
119
The right ventricular internal dimension is the widest point of the right ventricular cavity.
120 2.4 Immunoblot analysis: Technique was performed as described [15,20] using the following antibodies:
122
fatty acid synthase (ab22759) from Abcam Inc. (Cambridge, MA); β-actin (A2066) from Sigma-Aldrich;
123
phospho-Cav1.2 a1C (AB9022) from Chemicon (Temecula, CA); LDLr specific rabbit monoclonal
124
antibody (1:1000 dilution, AB52818 Abcam, Cambridge, MA), lipoprotein lipase (LPL) specific mouse
125
monoclonal antibody (1:1000 dilution, AB21356, Abcam), adipose triglyceride lipase (ATGL) specific
126
rabbit monoclonal antibody (1:1000 dilution, AB 109251), hormone sensitive lipase (HSL) specific rabbit
127
monoclonal antibody (1:1000 dilution, AB 45422), lipoprotein lipase (LPL) specific mouse monoclonal
128
antibody (1:1000 dilution, AB 21356) or TNF-α specific rabbit polyclonal antibody (1:1000 dilution,
129
AB6671, Abcam) were used as primary antisera. Horseradish peroxidase-conjugated goat anti-mouse
130
immunoglobulin (1:2000 dilution, Amersham Biosciences, Piscataway, NJ) or horseradish peroxidase-
131
conjugated goat anti-rabbit immunoglobulin (1:5000 dilution, Amersham Biosciences) were used to
132
detect specific protein bands (explained in Figure Legends) using a chemiluminescence system [14,17].
133
GDI (1: 10000 dilution, 71-0300, and rabbit polyclonal, Invitrogen, CA) and a secondary antibody
134
horseradish peroxidase conjugated goat anti-rabbit (1:2000 dilution, Amersham Biosciences) was used to
135
normalize protein loading.
SC
M AN U
TE D
EP
AC C
136
RI PT
121
137
2.5 Polymerase Chain Reaction Array: An RT2 Profiler (SA Biosciences, Valencia, CA) custom
138
designed PCR array for mouse genes involved in lipid metabolism, oxidative stress and inflammatory
139
signaling was used to analyze gene expression. Data analysis was performed normalized to the
140
expression of 18sRNA using the ∆∆CT method according to the manufacturer’s protocol
141
(SABiosciences) and as previously mentioned [14, 21].
142 6
ACCEPTED MANUSCRIPT
2.6 Immuno-histochemical analysis (IHC): Hearts were isolated, fixed in 10% neutral buffered
144
formalin, embedded in paraffin, cut in 5-mm sections with a microtome, and stained with hematoxylin
145
and eosin (H&E) as previously published [14]. Four to six sections of each heart were scored blindly.
146
For each myocardial sample, histologic evidence of myocarditis, cellular hypertrophy and inflammation
147
was graded on a six point scale ranging from 0 to 5+ as previously published. A zero score indicated
148
lowest or negligible changes and 4 the most damaged state. The levels of ApoB, UCP3, and CETP were
149
quantitated in the sections of right and left ventricles using anti-ApoB, anti-UCP3, and anti-CETP
150
antibodies (1:250 dilution) followed by Horseradish peroxidase-conjugated goat anti-rabbit
151
immunoglobulin (1:1000 dilution) by IHC analysis as previously mentioned [17]. The stain intensities of
152
the images were quantified using NIH-Image J program for four to six images of each heart.
M AN U
SC
RI PT
143
153
2.7 Cholesterol measurement: Cholesterol levels were quantified in the hearts and livers [22] of mice at
155
day 160 pi using a colorimetric assay kit, and samples were prepared and assayed following the
156
manufacturer’s protocol (Total cholesterol colorimetric assay kit, Cell Biolabs Inc., CA).
TE D
154
157
2.8 Soluble-RAGE (S-RAGE) measurement: sRAGE levels were quantified in the serum of mice at day
159
160 pi using a ELISA kit, and samples were prepared and assayed following the manufacturer’s protocol
160
(Rat/mouse soluble RAGE ELISA, Aviscera Bioscience, CA).
EP
158
AC C
161 162
2.9 Statistical Analysis: Data represent means ± S.E. Data were pooled and statistical analysis was
163
performed using a Student’s t-test (Microsoft Excel) as appropriate and significance differences were
164
determined as p values between < 0.05 and <0.001 as appropriate. Gene array analyses were done in
165
duplicates as described earlier [14, 21].
166 167
3. RESULTS 7
ACCEPTED MANUSCRIPT
3.1 Diet has no effect on the survival of mice during chronic Chagas disease: Earlier we demonstrated
169
that HFD increases the survival rate of T. cruzi infected mice during the acute stage of Chagas disease
170
[14, 15]. To study the effect of HFD on the mortality and pathogenesis of subsequent, chronic T. cruzi
171
infection, at d35 post infection we began feeding the infected mice with either a high fat diet (HFD, 60%
172
fat calories) or a control regular diet (RD, 10% fat calories) for approximately 18 weeks (till d160pi). We
173
observed no significant difference in the survival rate between infected, uninfected, HFD-fed and RD-fed
174
mice between d35pi and d160pi (two mice died in each group after d120pi because of bite wounds due to
175
fighting). As expected, HFD fed mice showed greater body weight compared to RD fed mice
176
(Supplementary Fig.1B). Also as expected, infected mice displayed lower body weights compared to
177
uninfected mice on the same diet (Supplementary Fig. 1B).
178
3.2 Diet regulates ventricular dilation during chronic Chagas disease: Earlier we demonstrated
179
significant alterations in cardiac morphology in T. cruzi infected mice during the acute phase infection,
180
including a reduction in the left ventricle internal diameter (LVID), an increase in the right ventricle
181
internal diameter (RVID), and an increase in the cardiac wall thickening (at both diastole and systole)
182
[14]. We also reported that these alterations in heart morphology were less pronounced in the acutely
183
infected mice fed on a HFD compared to the acutely infected mice fed on a RD [14]. Chronically infected
184
CD1 mice develop cardiomyopathy between d90 and d150pi [12, 17]. To investigate the effect of a switch
185
to HFD on the cardiac morphology in mice during the early and late stages of chronic T, cruzi infection,
186
we performed cardiac MRI analysis at d100 pi and d150 pi., respectively. Compared to RD fed uninfected
187
mice, RD fed infected mice demonstrated no significant difference in LVID and a significant decrease in
188
RVID (both diastole and systole) during the early chronic stage (d100pi) of infection and an increased
189
LVID (and no significant difference in the RVID) at the late chronic stage (d150 pi) of infection (Fig. 1).
190
Compared to RD fed uninfected mice, infected mice fed on a HFD showed no significant difference in the
191
LVID or RVID (except a significant decrease in LVID diastole) at d100 pi and displayed a significantly
192
increased RVID at d150 pi (Fig.1). The wall average (diastole) significantly increased in the infected RD 8
AC C
EP
TE D
M AN U
SC
RI PT
168
ACCEPTED MANUSCRIPT
mice and decreased in the infected HFD mice compared to RD fed uninfected mice (Fig.1). These data
194
demonstrated significant alterations in the cardiac morphology between the early and late chronic stages
195
of infection and showed that prolonged HFD intake causes RV dilation.
196
3.3 Histopathological changes in the heart: There were significant histological differences in the hearts
197
of infected (RD and HFD fed) mice compared to RD fed uninfected mice at both early (d120pi) and late
198
chronic stages (d160pi) of infection (Fig. 2A and 2B). Cellular hypertrophy and inflammation were
199
prominent in the infected hearts sections. The pattern of pathology (hypertrophy, inflammation and
200
accumulation of lipid droplets) differed between RV and LV (additional images are presented as
201
Supplementary Fig. 2): infected RD fed mice showed significantly higher levels of inflammation in the
202
RV compared to infected HFD mice, whereas there was no significant difference between the infected RD
203
and HFD mice in the levels of inflammation observed in the LVs at d120pi (Fig. 2A). At the later stage of
204
chronic infection (d160pi), the hearts obtained from infected RD fed mice displayed no significant
205
pathological changes in the RV compared to uninfected RD mice, but did display significant pathological
206
changes at the LV (Fig. 2B). Interestingly, HFD fed mice showed significantly increased pathology at
207
both RV and LV irrespective of infection status compared to uninfected RD fed mice (Fig. 2B). We
208
performed histological scoring of the hearts, with scores ranging from 0 to 5+ in the categories of
209
inflammation, cellular hypertrophy, lipid droplet accumulation and increased capillary size. Infected (RD
210
and HFD) animals had higher scores than uninfected RD fed animals at d120pi (Fig. 3). Infected HFD
211
animals had greater scores than infected RD fed animals at 160pi. These data demonstrate that infected
212
mice fed on a HFD are more susceptible to developing cardiac pathology involving both RV and LV
213
compared to RD fed mice during the late chronic stages of infection.
214
3.4 HFD increases cholesterol levels in the livers but not the hearts of the chronically infected mice:
215
Earlier we showed that cholesterol accumulation in the myocardium is associated with CCM in the
216
murine Chagas model and in a human CCM biopsy samples [14,23]. To evaluate the effect of HFD on
AC C
EP
TE D
M AN U
SC
RI PT
193
9
ACCEPTED MANUSCRIPT
cardiac cholesterol levels during late chronic infection, we measured the levels of cholesterol in the
218
hearts, as well as in the livers, of the mice fed on either a HFD or RD at 160dpi. The mice showed no
219
significant differences in the levels of cholesterol in the hearts between infected HFD fed and RD fed
220
mice (Supplementary Fig. 3). However, the livers of HFD fed mice (both infected and uninfected) showed
221
greater cholesterol levels than the RD fed mice (Supplementary Fig. 3). Also, the weights of hearts and
222
livers correlated with the cardiac levels of cholesterol in these experimental groups (Supplementary Figs
223
1(C&D) and 3).
224
To test whether LDL was a major source of cholesterol in the infected mice [14,23], we quantified ApoB
225
levels in the LV and RV separately at d120 and 160pi by IHC analysis (Fig.4 and Supplementary Fig. 3).
226
We found significant differences in ApoB levels between the RV and LV sections, between the infected
227
RD and HFD groups, and also between the early and late chronic time points (Supplementary Fig. 3).
228
During the early chronic phase (d120pi), ApoB levels of the LV significantly decreased in the infected
229
mice compared to uninfected mice irrespective of the diets. However, only the RV of the infected HFD
230
mice showed significantly reduced ApoB levels at d120pi. During the late chronic stage (d160pi), ApoB
231
levels significantly increased in both RV and LV of the infected RD mice compared to the infected HFD
232
mice (Supplementary Fig. 3).
233
3.5 HFD enhances disruption of cardiac lipid metabolism during chronic Chagas disease: Earlier we
234
demonstrated that T. cruzi infection affects cholesterol trafficking and efflux mechanisms and lipid
235
metabolism during acute infection [15]. To evaluate the effect of diet on regulating lipid metabolism
236
during the early and late stages of chronic infection, we measured the protein levels of cholesterol efflux
237
protein ATP binding cassette transporter 1 (Abca1), cholesterylester transfer protein (CETP), and lipid
238
oxidation regulator PPARα, in the hearts of the infected mice at d120pi and 160pi (Fig. 5). The protein
239
levels of Abca1, CETP and PPARα significantly increased in the infected HFD mice compared to
240
uninfected HFD mice at d120pi. The infected RD mice also demonstrated greater levels of CETP and
AC C
EP
TE D
M AN U
SC
RI PT
217
10
ACCEPTED MANUSCRIPT
PPARα compared to uninfected RD (no significant difference in Abca1 levels) at d120pi. During the late
242
chronic stage (d160pi), the infected HFD mice showed either no significant change or a decrease in the
243
cardiac levels of Abca1, CETP and PPARα compared to uninfected HFD mice. In the infected RD mice,
244
the levels of these proteins significantly increased compared to uninfected RD mice (Fig. 5A and Fig. 5a).
245
Overall, the levels of Abca1, CETP and PPARα were lower in the infected HFD mice compared to the
246
infected RD mice and also significantly reduced (except CETP) during the late chronic stage relative to
247
RD fed uninfected mice (Fig.5A and 5a). IHC analysis also demonstrated significantly reduced CETP
248
levels in both the RV and LV of the infected HFD mice compared to the infected RD mice (Supplemental
249
Fig. 4).
250
We also measured the cardiac levels of some of the following lipid metabolic proteins to investigate the
251
effect of HFD on the late chronic stage of infection. We measured the levels of lecithin–cholesterol
252
acyltransferase (LCAT), an enzyme that converts free cholesterol into cholesteryl ester, in the hearts of
253
mice at 160pi. Immunoblot analysis demonstrated a significant decrease in the levels of LCAT in the
254
infected HFD fed mice compared to all the other groups (Fig. 5B and 5b). These data suggest that HFD
255
significantly affects cardiac cholesterol metabolism at the later stages of chronic T. cruzi infection. We
256
also measured the cardiac levels of key proteins involved in fatty acid metabolism, such as fatty acid
257
synthase (FAS), acyl-coA synthase (ACSL1), ATP citrate lyase, and UCP3 by immunoblot analysis in the
258
hearts of mice at d160pi (Fig. 5B and 5b) . The levels of proteins involved in the fatty acid metabolism
259
were significantly decreased in the infected HFD mice compared to the infected RD mice. We also found
260
a significant decrease in UCP3 in the LVs of the infected HFD mice compared to all other experimental
261
groups – the quantitated intensities of the IHC images showed significant differences between RV and
262
LV, between the infected RD and infected HFD groups, and between the early and late chronic phases
263
(Supplementary Fig. 4).
AC C
EP
TE D
M AN U
SC
RI PT
241
11
ACCEPTED MANUSCRIPT
3.6 HFD aggravates mitochondrial oxidative stress during chronic CD: It has been demonstrated that
265
mitochondrial dysfunction and oxidative stress are involved in the pathogenesis of Chagasic
266
cardiomyopathy [8,13]. To evaluate the effect of prolonged HFD treatment on the cardiac mitochondrial
267
oxidative capacity in Chagas disease, we measured the protein levels of succinate dehydrogenase complex
268
flavoprotein subunit A (SDHA) and heat shock protein 60 (HSP-60) (Fig. 6A). SDHA is a major catalytic
269
subunit of succinate-ubiquinone oxidoreductase, a complex of the mitochondrial respiratory chain which
270
is vulnerable to reactive oxygen species (ROS) [24]. HSP60 is a chaperone originally identified in the
271
mitochondria, which is responsible for refolding and transportation of proteins between the mitochondrial
272
matrix and the cytoplasm of the cell [25]. HSP60 associates with a number of cytosolic proteins involved
273
in apoptosis and its level correlates with oxidative stress [25]. We found that SDHA1 and HSP60 levels
274
significantly increased in the hearts of infected RD mice and that only HSP60 levels were elevated in the
275
hearts of infected HFD mice compared to uninfected RD mice at d 120 pi (Fig.6A). However, in the late
276
chronic phase mice (d160 pi), infected HFD mice showed a significant decrease in SDHA1 levels (no
277
significant change was observed in the infected RD mice) compared to uninfected RD mice (Fig.6A).
278
HSP60 levels were significantly down regulated in both infected groups (i.e. RD and HFD). Additionally,
279
qPCR analysis showed that the mRNA levels of the genes involved in the mitochondrial oxidative
280
functions were significantly altered in the RV of the infected HFD mice compared to the infected RD
281
mice (Supplemental Table 1A). We also analyzed the levels of anti-oxidant genes, such as glutathione
282
peroxidases, peroxiredoxine1, catalase and super oxide dismutase in the RV and LV of the late chronic
283
mice and found that they were significantly reduced in both RV and LV of the infected HFD mice
284
compared to infected RD mice (Supplemental Table 1B).
285
3.7 HFD increases cardiac levels of RAGE and cleaved RAGE: The receptor for advanced glycation
286
end products (RAGE) mediates responses to cell danger and stress [26]. When bound by its many ligands
287
(which include advanced glycation end products, certain members of the S100/calgranulin family,
288
extracellular high-mobility group box 1, the integrin Mac-1, amyloid beta-peptide and fibrils), RAGE 12
AC C
EP
TE D
M AN U
SC
RI PT
264
ACCEPTED MANUSCRIPT
activates programs responsible for acute and chronic inflammation [27]. We found that during early
290
chronic stages of infection (d120pi), the cardiac levels of RAGE significantly increased in the infected
291
HFD mice compared to uninfected RD fed mice (Fig. 6B and 6b). Furthermore, immunoblot analysis
292
demonstrated significantly increased levels of the proteolytically cleaved RAGE (a.k.a. soluble RAGE) in
293
both uninfected and infected HFD fed mice compared to uninfected mice. During the late chronic stages
294
of infection (d160pi), the cardiac levels of RAGE significantly increased in the infected RD mice
295
compared to uninfected RD mice. However, unlike at d120pi, the levels of RAGE and cleaved RAGE
296
significantly decreased in the infected HFD mice compared to the infected RD mice at d160pi (Fig. 6B
297
and 6b). We also analyzed the serum levels of soluble RAGE (sRAGE) at d160pi using a RAGE ELISA
298
kit. The levels of sRAGE were significantly reduced (p≤0.0002) in the infected HFD mice compared to
299
RD fed uninfected mice (Supplementary Fig. 5).
300
3.8 HFD modulates cardiac inflammation during chronic Chagas disease: It has been shown that
301
inflammatory signaling plays a major role in determining cardiac pathogenesis in chronic Chagas disease
302
[6]. For instance, inflammation induced cardiac remodeling is observed both in the animal models of
303
Chagas disease and in Chagasic cardiac patients [28]. Thus, we analyzed the effect of HFD on cardiac
304
inflammatory cytokine levels. Immunoblot analysis demonstrated significantly decreased levels of pro-
305
inflammatory cytokines TNFα and IFNγ in the infected RD fed mice during the early chronic stage
306
(d120pi), but both of these cytokines significantly increased during the late chronic stage (d160pi)
307
compared to uninfected RD mice (Fig. 6C and 6c). The levels of TNFα in the infected HFD mice showed
308
no significant difference relative to uninfected HFD mice (d160pi). The levels of IFNγ were significantly
309
reduced in both the infected RD fed and HFD fed mice (p≤0.051) during the early stages of chronic
310
infection relative to RD fed uninfected mice (Fig. 6C and 6c). However, the levels of IFNγ significantly
311
increased in the infected RD mice compared to the infected HFD mice during later stages of chronic
312
infection. Interestingly, immunoblot analysis showed a significant increase in the levels of both TNFα and
313
IFNγ in the infected HFD mice compared to the infected RD mice at the early chronic stage, which 13
AC C
EP
TE D
M AN U
SC
RI PT
289
ACCEPTED MANUSCRIPT
reversed to significantly reduced levels by d160pi (Fig. 6C and 6c). The levels of pro-inflammatory
315
cytokines correlated with the levels of cardiac RAGE levels (Fig. 6A and 6a) in all experimental groups.
316
4. Discussion
317
In the present study we validated the role of HFD introduced after the acute stage and during the
318
indeterminate stage of Chagas disease as a regulator of the pathogenesis of CCM. In particular we
319
measured the effect of HFD on cardiac lipid metabolism and inflammation, and morphology during early
320
and late chronic stages of infection. We found that HFD significantly reduced cardiac pro-inflammatory
321
markers and increased cardiac dilation and dysfunction during later stages of chronic infection compared
322
RD in our murine Chagas model. Together, these data show that HFD intake during indeterminate/early
323
chronic stages increases the risk of developing cardiomyopathy and cardiac dysfunction.
324
The various techniques we employed to investigate cardiac structure and function clearly demonstrated
325
that during the late chronic stages (d150pi) of infection in HFD-fed mice there was a significant cardiac
326
dysfunction associated with right ventricular enlargement compared to RD-fed mice. Even though there
327
were no significant alterations at the LVID and RVID observed in the infected HFD fed mice compared
328
to uninfected RD- fed mice at an early time point of the chronic infection stage (d100pi), infected HFD-
329
fed mice developed increased RVID over an extended period of HFD feeding as shown by the MRI data
330
at d150pi (Fig. 1). Interestingly, infected RD fed mice showed significantly increased LVID (p≤0.05 -
331
0.01) and no significant change in RVID compared to uninfected RD mice at d150pi (Fig. 1). These
332
observations suggest that HFD and RD, which are composed of 60% and 70% (k cal) of fat and
333
carbohydrates respectively, differently regulate cardiac enlargement in infected mice. These MRI data
334
suggest that diet plays a major role in determining cardiac and ventricular enlargement during chronic
335
stages of infection.
AC C
EP
TE D
M AN U
SC
RI PT
314
14
ACCEPTED MANUSCRIPT
Previously we demonstrated that altered lipid metabolism of the heart contributes to myocarditis in acute
337
T. cruzi infection [13, 14, 23]. We showed that cardiac lipid metabolism is modulated by HFD, which
338
alters the cardiac pathogenesis of acute T. cruzi infection, resulting in reduced myocardial fibrosis,
339
inflammation and mortality of CD1 mice [13, 14]. We and others have reported cardiac lipid
340
accumulation that may regulate cardiac pathogenesis in chronic Chagas disease [13,14]. These
341
accumulated lipids can either be effluxed or utilized via mitochondrial oxidation to prevent cardiac
342
lipotoxicity. Our results here showed that HFD decreases the efficiency of clearing cardiac cholesterol
343
accumulation, as indicated by the reduced levels of the cholesterol efflux protein ABCA1 and free
344
cholesterol converting enzyme LCAT (Fig. 5). HFD also reduced fatty acid metabolism and oxidation as
345
demonstrated by reduced levels of cardiac PPARα and UCP3 (Fig. 5) in the infected mice. Increased
346
intracellular lipid accumulation causes mitochondrial stress and exacerbates mitochondrial oxidative
347
capacity, resulting in mitochondrial dysfunction [29]. While we observed significantly increased
348
mitochondrial oxidative function in the infected HFD mice at early stages of chronic infection, as
349
indicated by the increased cardiac levels of SDHA and UCP3, their levels significantly decreased at the
350
later stages of chronic infection (Figs. 5 and 6A). These information suggest that HFD treatment during
351
the early chronic stage overloads cardiac lipid levels and exceeds mitochondrial oxidative capacity (Fig.
352
6A), and increases oxidative stress (Table. 1), and prolonged HFD treatment results in the exhaustion of
353
mitochondrial function in the infected HFD mice. These data indicate that cholesterol efflux mechanisms
354
(Fig. 5), lipid oxidation (Fig. 5), and mitochondrial dysfunction (Fig. 6A) are all affected by HFD during
355
chronic stages of infection, resulting in aggravated cardiac lipotoxicity, vascular and cardiac accumulation
356
of lipid droplets, and vascular dilation (Fig. 6 and Table 1 ).
357
HFD also caused significant changes in the levels of cardiac inflammatory cytokines. While HFD
358
increased cardiac levels of the pro-inflammatory cytokines such as TNFα and IFNγ in the early chronic
359
phase (d120pi) compared to RD in infected groups, their levels significantly decreased in the late chronic
360
phase (d160pi), suggesting that increased cardiac lipid droplets (Fig. 3) may play a role in decreased 15
AC C
EP
TE D
M AN U
SC
RI PT
336
ACCEPTED MANUSCRIPT
TNFα levels. Indeed, the inverse regulation mechanisms between lipid droplets/adipocytes and TNFα
362
have been reported [30].Our data also showed significantly decreased levels of RAGE/proteolytically
363
cleaved RAGE in the heart, and reduced serum soluble RAGE in the infected HFD mice (Fig. 6B and Sup
364
Fig. 5). This result correlates well with the cardiac pro-inflammatory cytokine levels because increased
365
TNFα levels have been shown to positively regulate RAGE levels through nuclear factor-kappa B in
366
human vascular endothelial cells [26,27]. Increased soluble RAGE was protective against inflammation
367
during early chronic stage which diminished in the hearts of infected HFD mice at late chronic stage
368
suggesting a possible protective role of soluble RAGE in preventing CCM.
369
HFD is known to alter the metabolic state of the host, which in turn can regulate host immune signaling
370
[15, 31]. In recent decades, a western style diet high in fat has become more accessible in the endemic
371
regions of Chagas disease, which may adversely impact the outcome of chronic Chagas disease [18, 19].
372
Indeed, our data suggest that HFD aggravates the pathogenesis of cardiomyopathy by causing
373
mitochondrial dysfunction due to elevated cardiac lipidopathy. Fat and carbohydrate rich diets
374
differentially altered ventricular enlargements (i.e. RV vs LV) during the late chronic stage. In light of our
375
studies, CCM may be considered not just a chronic inflammatory disease, but also one with an associated
376
metabolic pathology. Further dietary studies need to be conducted to completely understand the
377
mechanisms of the pathogenesis of CCM and their metabolic regulation.
SC
M AN U
TE D
EP
378
RI PT
361
5. CONFLICT OF INTEREST STATEMENT
380
None of the authors have conflict of interest.
381
AC C
379
382
6. ACKNOWLEDGEMENTS:
383
We thank Dazhi Zhao at the Albert Einstein College of Medicine for providing technical help. Erika Shor
384
at the Public Health Research Institute for a critical reading of the manuscript. 16
ACCEPTED MANUSCRIPT
385
Reference 1. Montgomery SP, Starr MC, Cantey PT, Edwards MS, Meymandi SK. Neglected parasitic
387
infections in the United States: Chagas disease. Am J Trop Med Hyg 2014;90 :814-8.
RI PT
386
2. Steverding D. The history of Chagas disease. Parasit Vectors. 2014; 7:317.
389
3. Rassi Jr A, Neto M, Antonio J, Rassi A. Chronic Chagas cardiomyopathy: a review of the main
390
pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole
391
Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial. Mem Inst Oswaldo Cruz. 2017;
392
12:224-235
394
395
M AN U
393
SC
388
4. Mensah GA, Burns KM, Peprah EK, Sampson UK, Engelgau MM. Opportunities and challenges in chronic chagas cardiomyopathy. Glob Heart 2015 ;3:203-7
5. Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC et al. Perspectives on Trypanosoma cruzi–induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009;
397
51:524-39.
400 401
402 403
404 405
inflammation and oxidative stress. J Am Heart Assoc. 2013; 2: e000539.
EP
399
6. Machado FS, Tanowitz HB, Ribeiro AL. Pathogenesis of Chagas cardiomyopathy: role of
7. Machado FS, Jelicks LA, Kirchhoff LV, Shirani J, Nagajyothi F, Mukherjee S et al. Chagas heart disease: report on recent developments. Cardiol Rev. 2012 ;2:53-65
AC C
398
TE D
396
8. Zacks MA, Wen JJ, Vyatkina G, Bhatia V, Garg N. An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An Acad Bras Cienc. 2005 ;77 :695-15.
9. Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev. 2011;24:592-30.
17
ACCEPTED MANUSCRIPT
406
10. https://www.cdc.gov/parasites/chagas/gen_info/detailed.html
407
11. Botoni FA, Ribeiro AL, Marinho CC, Lima MM, Nunes MD, Rocha MO. Treatment of Chagas
409
cardiomyopathy. Biomed Res Int. 2013; 24;2013 :849504
RI PT
408
12. De Souza AP, Tanowitz HB, Chandra M, Shtutin V, Weiss LM, Morris SA, Factor SM, Huang H, Wittner M, Shirani J, Jelicks LA. Effects of early and late verapamil administration on the
411
development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain)
412
infection. Parasitol Res 2004; 92:496-501.
414
13. Johndrow C, Nelson R, Tanowitz H, Weiss LM, Nagajyothi F. Trypanosoma cruzi infection
M AN U
413
SC
410
results in an increase in intracellular cholesterol. Microbes Infect 2014; 4 :337-44
415
14. Nagajyothi F, Weiss LM, Zhao D, Koba W, Jelicks LA, Cui M, et al. High fat diet modulates
416
Trypanosoma cruzi infection associated myocarditis. PLoS Negl Trop Dis 2014; 8:e3118. 15. Brima W, Eden DJ, Mehdi SF, Bravo M, Wiese MM, Stein J, et al. The brighter (and
TE D
417 418
evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection
419
in CD-1 mice. Diabetes Metab Res Rev 2015; 31:346-59.
422 423
424 425
EP
421
16. Dhiman M, Garg NJ. NADPH oxidase inhibition ameliorates Trypanosoma cruzi‐induced myocarditis during Chagas disease. J Pathol 2011;225:583-96. 17. Andrade DV, Gollob KJ, Dutra WO. Acute chagas disease: new global challenges for an old
AC C
420
neglected disease. PLoS Negl Trop Dis 2014;8:e3010.
18. Bermudez OI, Tucker KL. Trends in dietary patterns of Latin American populations. Cad Saude Publica. 2003; 19:S87-99.
18
ACCEPTED MANUSCRIPT
426 427
428
19. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 2012;70 :3-21. 20. Combs TP, Nagajyothi F, Mukherjee S, de Almeida CJ, Jelicks LA, Schubert W, et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 2005; 280:
430
24085-94.
431
RI PT
429
21. Zhao D, Lizardo K, Cui MH, Ambadipudi K, Lora J, Jelicks LA, et al. Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease. Microbes Infect 2016
433
;18 :675-86.
22. Lizardo K, Almonte V, Law C, Aiyyappan JP, Cui MH, Nagajyothi JF. Diet regulates liver
M AN U
434
SC
432
435
autophagy differentially in murine acute Trypanosoma cruzi infection. Parasitol Res 2017;116
436
:711-23.
437
23. Nagajyothi F, Weiss LM, Silver DL, Desruisseaux MS, Scherer PE, Herz J, et al. Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis 2011; 5:
439
e953.
441
24. Nojiri H, Shimizu T, Funakoshi M, Yamaguchi O, Zhou H, Kawakami S, et al. Oxidative stress causes heart failure with impaired mitochondrial respiration J Biol Chem 2006 ;281:33789-01.
EP
440
TE D
438
25. Kaufman BA, Kolesar JE, Perlman PS, Butow RA. A function for the mitochondrial chaperonin
443
Hsp60 in the structure and transmission of mitochondrial DNA nucleoids in Saccharomyces
444
445 446
AC C
442
cerevisiae. J Cell Biol. 2003;163:457-61.
26. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, et al . A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of
447
the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
448
FASEB J 2008 ;22:3716-27.
19
ACCEPTED MANUSCRIPT
27. Chuah YK, Basir R, Talib H, Tie TH, Nordin N. Receptor for advanced glycation end products
449
and its involvement in inflammatory diseases. Int J Inflam 2013 ; ;2013:403460
450
28. Higuchi MD, Benvenuti LA, Martins Reis M, Metzger M. Pathophysiology of the heart in
451
Chagas’ disease: current status and new developments. Cardiovasc Res 2003 ;60:96-07.
453
29. Aon MA, Bhatt N, Cortassa SC. Mitochondrial and cellular mechanisms for managing lipid
RI PT
452
excess. Front Physiol. 2014; 5:282
SC
454
30. Green A, Rumberger JM, Stuart CA, Ruhoff MS. Stimulation of lipolysis by tumor necrosis
455
M AN U
factor-α in 3T3-L1 adipocytes is glucose dependent. Diabetes. 2004 ;53:74-81.
456
31. Fisher-Wellman KH, Ryan TE, Smith CD, Gilliam LA, Lin CT, Reese LR, et al. A direct
457 458
comparison of metabolic responses to high-fat diet in C57BL/6J and C57BL/6NJ mice. Diabetes.
459
2016 ;65 :3249-61.
TE D
460 Figure Legends:
462
Figure 1. Diet regulates the morphology of the heart during early (A, 100DPI) and late (B, 150DPI)
463
stages of chronic infection (n=8).
464
A.
465
ventricle internal diameter (LVID) in the infected HFD fed mice compared with infected RD fed mice at
466
early chronic stage of infection d100pi. The infected HFD mice showed no significant difference to
467
uninfected RD mice (LVID systole). MRI analysis both at diastole and systole condition showed
468
significantly decrease in the right ventricle internal diameter (RVID) in the infected RD fed mice
469
compared with uninfected RD fed mice at d100pi. However, the infected HFD mice showed no
470
significant difference to uninfected RD mice with RVID measurements at d100pi.B.
EP
461
AC C
MRI analysis both at diastole and systole condition showed significantly decrease in the left
20
ACCEPTED MANUSCRIPT
B.
MRI analysis both at diastole and systole condition showed a significant decrease in the left
472
ventricle internal diameter (LVID) and wall thickening of the ventricles in the infected HFD mice
473
compared to infected RD mice at late stages of chronic infection (d150pi). More importantly, the infected
474
HFD mice showed significantly increased RVID both at diastole and systole condition compared to all the
475
other experimental groups at d150pi. The error bars represent standard error of the mean. * p ≤ 0.05, ** p
476
≤ 0.01 or *** p ≤ 0.001 compared to uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤
477
0.001compared to infected RD mice.
SC
RI PT
471
478
Figure 2. Histology of the myocardium of mice during early (A) and late (B) stages of chronic
480
infection (n = 8, minimum five images/section were analyzed).
481
(A)
482
infected mice relative to uninfected mice fed on either RD or HFD and in uninfected HFD mice hearts
483
compared to the hearts of uninfected RD fed mice at d120pi.
484
(B)
485
infected HFD fed mice compared to the infected RD fed mice in RV at d160pi. The hearts of infected
486
HFD mice showed increased levels of lipid droplets and capillary size in LV compared to the infected RD
487
mice (Additional images are presented in supplemental Fig. 2). (arrow – inflammatory infiltrates, arrow
488
head –hypertrophy and bar -100um).
TE D
H&E staining showed significantly increased inflammatory infiltrates (arrow) in the hearts of
EP
H&E staining showed significantly more damage (inflammation and hypertrophy) in the hearts of
AC C
489
M AN U
479
490
Figure 3. Histological grading of the H&E sections.
491
Histological grading of cardiac pathology was carried out in the experimental groups and classified in
492
terms of degree of inflammation (inflammatory infiltrates), hypertrophy, presence of lipid
493
droplets/granules and increase of capillary size. Each class was graded on a six point scale ranging from 0
494
to 5+ as discussed in the Methods section, and presented as a bar graph. The error bars represent standard 21
ACCEPTED MANUSCRIPT
495
error of the mean. * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to uninfected RD mice. # p ≤ 0.05,
496
## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice.
497 Figure 4. HFD reduces cardiac ApoB levels during chronic infection.
499
(A) IHC analysis using anti-ApoB staining demonstrated a significant decrease in the levels of ApoB both
500
in the RV and LV of infected HFD fed mice compared with uninfected (RD and HFD) mice during early
501
chronic infection (d120pi) (n = 8).
502
(B) Cardiac ApoB levels significantly decreased in both the RV an LV of infected HFD mice compared to
503
the infected RD mice at later stages of chronic infection (d160pi) as indicated by IHC analysis (n=8).
504
These images were quantitated and presented as bar graphs in Supplemental Figure 3.
M AN U
SC
RI PT
498
505 506
Figure 5. Immunoblot analysis of the hearts demonstrated that HFD enhances disruption of cardiac
507
lipid metabolism during chronic Chagas disease.
508
(A)
509
infection. The levels of these proteins significantly decreased in infected HFD mice compared to infected
510
RD mice during the later stages of chronic infection (d160pi) (n=8).
511
(a) Fold changes in the protein levels of Abca1, CETP and PPARα were normalized to GDI expression
512
and represented as the bar graph.
513
(B)
514
in fatty acid metabolism such as fatty acid synthase (FAS), acyl-coA synthase (ACSL1), and ATP citrate
515
lyase were significantly decreased in the infected HFD fed mice compared to infected RD fed mice during
516
late chronic stage (d160pi) (n=8).
517
(b) Fold changes in the protein levels of LCAT, FAS, ACSL1, and ATP citrate lyase were normalized to
518
GDI expression and represented as the bar graph.
EP
TE D
Protein levels of Abca1, CETP and PPARα were altered in the hearts during chronic T. cruzi
AC C
The cardiac levels of lecithin–cholesterol acyltransferase (LCAT) and the key proteins involved
22
ACCEPTED MANUSCRIPT
519
The error bars represent standard error of the mean. * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to
520
uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice.
521 Figure. 6: Immunoblot analysis of the hearts demonstrated that HFD affects the mitochondrial
523
respiratory response and cardiac inflammation during chronic Chagas disease.
524
(A) Protein levels of SDHA1 and HSP 60 were altered in the hearts during chronic T. cruzi infection. The
525
levels of SDHA1 proteins significantly decreased in infected HFD mice compared to infected RD mice
526
during the later stages of chronic infection (d160pi) (n=8).
527
(a) Fold changes in the protein levels of SDHA1 and HSP60 were normalized to GDI expression and
528
represented as the bar graph.
529
(B) Protein levels of RAGE (52kD) and cleaved RAGE (48 and 25kD) were altered in the hearts during
530
chronic T. cruzi infection. The levels of cleaved RAGE (25kD) were significantly increased in the
531
infected HFD mice compared to infected RD mice at early chronic stage (d120pi), but were then
532
significantly reduced during the later stages of chronic infection (d160pi) (n=8).
533
(b) Fold changes in the protein levels of RAGE (52kD) and cleaved RAGE (48 and 25kD) were
534
normalized to GDI expression and represented as the bar graph.
535
(C)
536
levels of TNFα and IFNγ proteins significantly decreased in the infected HFD mice compared to infected
537
RD mice during the later stages of chronic infection (d160pi) (n=8).
538
(c) Fold changes in the protein levels of TNFα and IFNγ were normalized to GDI expression and
539
represented as the bar graph.
540
The error bars represent standard error of the mean. * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to
541
uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice.
TE D
M AN U
SC
RI PT
522
AC C
EP
Protein levels of TNFα and IFNγ were altered in the hearts during chronic T. cruzi infection. The
542 543 23
ACCEPTED MANUSCRIPT
Supplementary Figure. 1:
545
A : Experimental design
546
B-D: HFD alters body weight (B), and the heart (C) and liver (D) weights in late chronic infection
547
(d160pi).
548
Significance represent mean values of the data with Standard Error of the mean (SEM) as vertical lines.
549
(The error bars represent standard error of the mean * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to
550
uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice).
SC
RI PT
544
551
Supplementary Figure. 2: Histology of the myocardium of mice during early and late stages of
553
chronic infection (additional images, n=8).
554
(A)
555
uninfected HFD mice hearts compared to the hearts of uninfected RD fed mice at d120pi (bar -100um)
556
(B)
557
infected RD fed mice in RV at d160pi. The infected HFD mice showed increased levels of lipid droplets
558
and capillary size in LV compared to the infected RD mice (bar -100um).
M AN U
552
H&E staining displayed significantly more damage in infected (fed on either RD or HFD) and
TE D
H&E staining displayed significantly more damage in infected HFD fed mice compared to the
559
Supplementary Figure. 3: The levels of cardiac cholesterol (A) and ApoB (B) during chronic T.
561
cruzi infection (n=8).
562
(A)
563
levels in the livers and not in the hearts of the chronic infected mice as demonstrated by a colorimetric
564
analysis.
565
(B)
566
between the infected RD and infected HFD groups, and also between the early (d120pi) and late (d160pi)
567
chronic time points. Five images from each section were quantified using NIH image-J program. Bars
568
represent mean values of the data with SEM as vertical lines.
EP
560
AC C
T. cruzi infection increases cholesterol levels in the hearts at d160pi. HFD increases cholesterol
IHC images of ApoB staining (Figure 5) showed significant difference between RV and LV, and
24
ACCEPTED MANUSCRIPT
569
(The error bars represent standard error of the mean * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to
570
uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice).
571 Supplementary Figure. 4: Prolonged HFD treatment reduced cardiac UCP3 levels during late
573
chronic infection (d160pi, n=8).
574
(A)
575
the infected RD and infected HFD groups during early chronic stage (d120pi).
576
(B)
577
the infected RD and infected HFD groups during late chronic stage (d160pi).
578
(C)
579
each section were quantified using NIH image-J program. Bars represent mean values of the data with
580
SEM as vertical lines.
581
Significance represent mean values of the data with Standard Error of the mean (SEM) as vertical lines.
582
(The error bars represent standard error of the mean * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to
583
uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice).
RI PT
572
SC
IHC images of UCP3 staining showed significant difference between RV and LV, and between
M AN U
IHC images of UCP3 staining showed significant difference between RV and LV, and between
TE D
IHC images of UCP3 staining were quantified and represented as bar graph. Five images from
584
Supplementary Figure. 5: The serum levels of soluble RAGE during late stage of chronic infection
586
quantified by Elisa and represented as a bar graph (n=8).
587
The measurements showed significant difference between infected/uninfected RD and infected HFD
588
groups.
589
Significance represent mean values of the data with Standard Error of the mean (SEM) as vertical lines.
590
(The error bars represent standard error of the mean * p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to
591
uninfected RD mice. # p ≤ 0.05, ## p ≤ 0.01 or ### p ≤ 0.001compared to infected RD mice).
AC C
EP
585
592
25
ACCEPTED MANUSCRIPT
Supplementary Table.1: Chronic infected mice fed on RD and HFD displayed different mRNA
594
levels of the genes involved in mitochondrial oxidation (A) and anti-oxidative stress (B) in the right
595
and left ventricles (RV and LV) as demonstrated by qPCR analysis. (n = 8; fold change presented as
596
Mean. Significance represent mean values of the data with Standard Error of the mean (± SEM)
597
*p ≤ 0.05, ** p ≤ 0.01 or *** p ≤ 0.001 compared to uninfected RD mice).
RI PT
593
598
SC
599 600
M AN U
601 602
AC C
EP
TE D
603
26
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT